DYSPORT ABOBOTULINUMTOXINA DYSCOVERY
"DYSPORT ABOBOTULINUMTOXINA DYSCOVERY" is a word mark owned by Ipsen Biopharm Limited, filed at the USPTO on October 26, 2026. It is under examination and covers classes 41 and 42.
- Status
- Under examination
- Since October 26, 2026
- Filed
- October 26, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50181395
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 2 classes
Who owns DYSPORT ABOBOTULINUMTOXINA DYSCOVERY
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Ipsen Biopharm Limited
Wrexham, United Kingdom
Representative
Ben Natter
Haug Partners, LLP
What the mark covers
The products and services DYSPORT ABOBOTULINUMTOXINA DYSCOVERY is filed for, grouped by Nice class.
Educational services, namely, providing in-person and online courses and training in the field of healthcare; providing personalized in-person and online educational courses and training in the field of healthcare based on users' profiles, interests, and engagement; educational services, namely, providing educational and training programs for healthcare professionals in the field of healthcare
Providing temporary use of online non-downloadable software featuring artificial intelligence for providing personalized educational content and recommending educational courses based on users' profiles, interests, and engagement; providing temporary use of online non-downloadable software for curating and recommending educational and training content for healthcare professionals
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application entered
About DYSPORT ABOBOTULINUMTOXINA DYSCOVERY
Who owns the trademark "DYSPORT ABOBOTULINUMTOXINA DYSCOVERY"?
The USPTO trademark "DYSPORT ABOBOTULINUMTOXINA DYSCOVERY" (application 50181395) is owned by Ipsen Biopharm Limited.
What is the status of "DYSPORT ABOBOTULINUMTOXINA DYSCOVERY"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull DYSPORT ABOBOTULINUMTOXINA DYSCOVERY and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a17d7a-b4f4-7472-93e0-6af72f8f468b
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a17d7a-b4f4-7472-93e0-6af72f8f468b",
"object": "trademark",
"mark_text": "DYSPORT ABOBOTULINUMTOXINA DYSCOVERY",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50181395",
"filing_date": "2026-10-26",
"nice_classes": [
41,
42
],
"owners": [
{
"name": "IPSEN BIOPHARM LIMITED",
"entity_id": "ent_019eb708-e440-75d9-a932-4d18c18228d2"
}
]
}